Memorial Sloan Kettering Cancer Center
2,080
324
728
1,201
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.7%
118 terminated/withdrawn out of 2080 trials
91.1%
+4.6% vs industry average
4%
91 trials in Phase 3/4
35%
425 of 1201 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (2080)
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
Role: lead
Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
Role: lead
Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies
Role: lead
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
Role: lead
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Role: lead
A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers
Role: lead
Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer
Role: lead
A Study of Isoquercetin in People With Ovarian Cancer
Role: lead
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
Role: lead
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
Role: lead
Endoprosthetic Replacement for Pathological Fractures of the Hip: A 35-year Update
Role: lead
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
Role: lead
A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble Swallowing
Role: lead
A New Psychotherapy Intervention for Older Cancer Patients
Role: lead
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
Role: lead
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
Role: lead
A Study of Tarlatamab for People With Prostate Cancer
Role: lead
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Role: lead
Implementation and Effectiveness Trial of HN-STAR
Role: collaborator
LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma
Role: lead